Osteoporosis is not inevitable – Austrian study indicates "practice change" for breast cancer patients

Vienna: With the largest breast cancer study conducted in Austria, ABCSG 18, and with support from MedUni Vienna, the renowned Austrian Breast & Colorectal Cancer Study Group (ABCSG) has demonstrated that it is possible to protect patients from osteoporosis following endocrine cancer treatment.
The results of ABCSG 18, a placebo-controlled adjuvant study involving 3,425 post-menopausal breast cancer patients, indicate with surprising clarity that it is easy to reduce treatment-related osteoporosis and bone fractures, which are an adverse side-effect of adjuvant endocrine therapy with aromatase inhibitors, without exposing patients to any additional toxicity.

Resolving the Paradox of Vitamin D Deficiency in Black Populations

Mass General Hospital. US: Reviewing recent studies into the potential health consequences of vitamin D deficiency, the Institute of Medicine concluded that the clearest impact is on bone health. Yet while black subjects consistently have lower vitamin D levels than whites, their bones tend to be healthier. They have less osteoporosis, fewer fractures and higher bone density.